Pharma sector Current Affairs - 2020

Mexico Government approves world’s 1st Dengue fever vaccine named Dengvaxia

Mexico Government has approved world’s first-ever Dengue fever vaccine branded as Dengvaxia for the public use. Key facts Dengvaxia has been manufactured by French pharmaceutical manufacturer Sanofi Pasteur. It has been designed to protect people in the 9-45 age groups from all four subtypes of the virus. The vaccine was produced as the result of Read More…

Pfizer to take over Allergan in blockbuster merger deal of $160 billion

US drugs giant Pfizer Inc. has struck upon a deal to buy Ireland based Allergan for 160 billion dollars making it the biggest pharmaceuticals merger deal in history of healthcare sector. The blockbuster merger would create the world’s biggest drugmaker to be called Pfizer Plc with its headquarters in Dublin, Ireland. Under this deal, Allergan Read More…

Health Ministry inaugurates country’s first AMRIT outlet at AIIMS in New Delhi

Union Ministry of Health & Family Welfare has opened country’s first Affordable Medicines and Reliable Implants for Treatment (AMRIT) outlet at AIIMS in New Delhi to sell drugs at highly discounted rates. The retail outlet was inaugurated by Union Health Minister J P Nadda at AIIMS campus in New Delhi under the AMRIT programme which Read More…

EU bans marketing of around 700 generic medicines of GVK Biosciences

European Union (EU) has banned the marketing of around 700 generic medicines among its member countries. This is the largest suspension imposed on the sales and distribution of generic drugs ordered by EU which will come into effect on August 21, 2015 and it will be applicable to all 28 member nations. These generic medicines were Read More…

Lupin acquires US pharmaceutical firm Gavis

Indian pharmaceutical major Lupin has acquired US based Gavis Pharmaceuticals in cash-free and debt-free transaction for 880 million dollars (around 5,606 crore rupees). In this regard, Lupin has entered into definite agreement with Gavis Pharmaceuticals LLC and its subsidiary Novel Laboratories Inc. This acquisition will help the Indian company to expand and deepen its presence Read More…